|POZEN Inc. Announces Plans to Webcast First-Quarter Earnings Conference Call|
CHAPEL HILL, N.C., April 26 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, today announced it plans to conduct a conference call following the release of financial results for the first quarter ended March 31, 2001. The company will release earnings before the market opens on Monday, April 30, 2001. John R. Plachetka, Pharm.D., POZEN's chairman, president and chief executive officer, and Matthew E. Czajkowski, chief financial officer, will host the conference call the same day at 11:00 a.m. Eastern Daylight Time.
The conference call will be simulcast live on the Internet, and can be accessed by logging on to http://www.streetevents.com . A replay will be available at this site, as well as on the Investor Relations section of the company's website, http://www.pozen.com , for seven days.
North Carolina-based POZEN Inc. is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. The company's initial focus is migraine, where it has built a robust portfolio of four product candidates through a combination of innovation and in-licensing. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."
POZEN is on the Internet at http://www.pozen.com